Latest 10-K annual reports

CNO Financial Group's 2025 net income declined significantly due to one-time charges, though operating income saw a modest increase, driven by strong premium collections and strategic business exits.

Palomar Holdings, a specialty insurer, announced significant premium growth and profitability in 2025, driven by strategic acquisitions and product diversification.

BridgeBio Pharma, Inc. reports significant commercial uptake for Attruby and positive Phase 3 clinical trial results for multiple pipeline candidates, despite continued net losses.

Wells Fargo & Company announced a significant increase in net income and diluted earnings per share for 2025, alongside the removal of its asset growth limitation by the Federal Reserve Board.

LTC Properties, Inc. reports its 2025 annual results, highlighting a strategic shift to a Seniors Housing Operating Portfolio (SHOP) model, significant property transactions, and a write-off of effective interest receivable.

Verra Mobility Corporation announced a significant 11.4% increase in total revenue for fiscal year 2025, reaching $979.1 million, alongside successful debt refinancing and a substantial rise in net income.

Range Resources Corporation reported a significant increase in net income and production for 2025, driven by higher realized prices and strategic capital investments, while also increasing dividends and repurchasing shares.

Pentair plc delivered robust financial performance in 2025 with increased net sales, gross profit, and diluted EPS, alongside a significant dividend hike and new share repurchase authorization.

Truist Financial Corporation announced a significant increase in net income for 2025, driven by loan and deposit growth, and authorized a new $10 billion share repurchase program.

Henry Schein reports 4.0% net sales growth in 2025, navigating the residual impact of a 2023 cyber incident and preparing for a CEO transition while advancing its BOLD+1 strategic plan.

Bel Fuse Inc. reported a significant increase in net sales and gross profit for 2025, driven by strong demand in aerospace, defense, and networking, and the full-year contribution of the Enercon acquisition, despite an impairment charge for its Innolectric investment.

Kiniksa Pharmaceuticals International, plc reported significant product revenue growth in 2025, driven by ARCALYST sales, while advancing its pipeline with KPL-387 and KPL-1161.

AbCellera Biologics Inc. reported a 161% revenue increase and reduced net loss in 2025, driven by a patent settlement and clinical pipeline advancements.

Luxfer Holdings PLC reported a decrease in net sales but an increase in adjusted net income for 2025, driven by strategic divestitures and operational improvements despite softness in some end-markets.

Vaxcyte initiated multiple Phase 3 trials for its 31-valent pneumococcal vaccine candidate, VAX-31, following positive Phase 1/2 results and expanded Breakthrough Therapy Designation, while also raising $632.5 million in a public offering.

CeriBell, Inc. announced a 36% revenue increase to $89.1 million in 2025, driven by expanded adoption of its AI-powered Ceribell System and new FDA clearances for delirium and pediatric/neonatal seizure monitoring, despite continued net losses.

Vertex, Inc. announced a significant turnaround to net income in 2025, alongside robust revenue growth and strategic investments in AI and global e-invoicing solutions, despite a slight dip in customer retention metrics.

Celanese Corporation reported a net loss of $1.151 billion for 2025, driven by lower sales volumes, pricing pressures, and significant goodwill and intangible asset impairment losses, despite deleveraging efforts.

Innovex International, Inc. announced a 48% increase in revenues for 2025, driven by strategic acquisitions and market share gains, despite a decline in net income due to prior year's non-recurring gains.

Stanley Black & Decker reports 2025 revenues of $15.1 billion, exceeding cost reduction targets while navigating portfolio divestitures and legal challenges.

New Mountain Finance Corporation reported a net decrease in net assets for 2025, driven by significant unrealized depreciation, while announcing a strategic asset sale and a quarterly dividend.

Addus HomeCare Corporation reported a significant increase in net service revenues and net income for the fiscal year ended December 31, 2025, driven by organic growth and strategic acquisitions across its personal care, hospice, and home health segments.

BlueLinx Holdings Inc. reports a significant decline in net income and gross profit for fiscal 2025 despite a slight increase in net sales, driven by strategic acquisition and volume growth offset by pricing pressures.

Northern Trust Corporation reported a 2% decrease in total revenue for 2025, driven by lower noninterest income, despite an 11% increase in net interest income and robust capital ratios.

Avanos Medical, Inc. reported a significantly reduced net loss in 2025, driven by strategic acquisitions and divestitures, despite ongoing restructuring costs and a goodwill impairment.

Old Dominion Freight Line reports a decline in 2025 revenue and net income amidst a soft domestic economy, while maintaining strong customer service and yield management.

DigitalOcean Holdings, Inc. announced a 15% revenue increase to $901.4 million in 2025, alongside a 207% surge in net income, fueled by significant growth in Digital Native Enterprise customers and AI/ML platform expansion.

Atlas Energy Solutions Inc. reported a net loss of $50.3 million in 2025, driven by declining proppant prices and increased operating costs, despite strategic acquisitions and growth in its power segment.

Offerpad Solutions Inc. reports a significant revenue decline in 2025 due to reduced home sales, but narrows its net loss through cost-cutting and strategic focus on higher-margin services, while addressing NYSE listing compliance.

Organon & Co. reported a 3% decrease in 2025 worldwide sales to $6.2 billion, a $301 million goodwill impairment, and identified material weaknesses in internal controls, while pursuing debt reduction and portfolio adjustments.